Pannexin-3 stabilizes the transcription factor Bcl6 in a channel-independent manner to protect against vascular oxidative stress
Abigail G Wolpe,Melissa A Luse,Christopher Baryiames,Wyatt J Schug,Jacob B Wolpe,Scott R Johnstone,Luke S Dunaway,Zuzanna J Juśkiewicz,Skylar A Loeb,Henry R Askew Page,Yen-Lin Chen,Vikram Sabapathy,Caitlin M Pavelec,Brent Wakefield,Eugenia Cifuentes-Pagano,Mykhaylo V Artamonov,Avril V Somlyo,Adam C Straub,Rahul Sharma,Frank Beier,Eugene J Barrett,Norbert Leitinger,Patrick J Pagano,Swapnil K Sonkusare,Stefanie Redemann,Linda Columbus,Silvia Penuela,Brant E Isakson,Abigail G. Wolpe,Melissa A. Luse,Wyatt J. Schug,Jacob B. Wolpe,Scott R. Johnstone,Luke S. Dunaway,Zuzanna J. Juśkiewicz,Skylar A. Loeb,Henry R. Askew Page,Caitlin M. Pavelec,Mykhaylo V. Artamonov,Avril V. Somlyo,Adam C. Straub,Eugene J. Barrett,Patrick J. Pagano,Swapnil K. Sonkusare,Brant E. Isakson
DOI: https://doi.org/10.1126/scisignal.adg2622
IF: 9.517
2024-02-01
Science Signaling
Abstract:Targeted degradation regulates the activity of the transcriptional repressor Bcl6 and its ability to suppress oxidative stress and inflammation. Here, we report that abundance of endothelial Bcl6 is determined by its interaction with Golgi-localized pannexin 3 (Panx3) and that Bcl6 transcriptional activity protects against vascular oxidative stress. Consistent with data from obese, hypertensive humans, mice with an endothelial cell–specific deficiency in Panx3 had spontaneous systemic hypertension without obvious changes in channel function, as assessed by Ca 2+ handling, ATP amounts, or Golgi luminal pH. Panx3 bound to Bcl6, and its absence reduced Bcl6 protein abundance, suggesting that the interaction with Panx3 stabilized Bcl6 by preventing its degradation. Panx3 deficiency was associated with increased expression of the gene encoding the H 2 O 2 -producing enzyme Nox4, which is normally repressed by Bcl6, resulting in H 2 O 2 -induced oxidative damage in the vasculature. Catalase rescued impaired vasodilation in mice lacking endothelial Panx3. Administration of a newly developed peptide to inhibit the Panx3-Bcl6 interaction recapitulated the increase in Nox4 expression and in blood pressure seen in mice with endothelial Panx3 deficiency. Panx3-Bcl6-Nox4 dysregulation occurred in obesity-related hypertension, but not when hypertension was induced in the absence of obesity. Our findings provide insight into a channel-independent role of Panx3 wherein its interaction with Bcl6 determines vascular oxidative state, particularly under the adverse conditions of obesity.
cell biology,biochemistry & molecular biology